Pearl River Capital, LLC Moderna, Inc. Transaction History

Pearl River Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $506,657 - $834,049	5,006 New	5,006 $594,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $496,804 - $810,722	-2,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $488,180 - $1.07 Million	2,200 New	2,200 $847,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $872,735 - $1.58 Million	-6,718 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $402,765 - $686,080	3,689 Added 121.79%	6,718 $880,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $199,126 - $514,505	3,029 New	3,029 $316,000
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $221,000 - $385,754	-4,067 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $72,157 - $194,560	2,432 Added 148.75%	4,067 $261,000
Q1 2020 May 06, 2020	BUY	$17.78 - $31.58 $29,070 - $51,633	1,635 New	1,635 $49,000
Q2 2019 Aug 12, 2019	SELL	$13.7 - $28.34 $43,401 - $89,781	-3,168 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$14.45 - $23.7 $45,777 - $75,081	3,168 New	3,168 $64,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.